- Home
- SNSE vs DSS Comparison
SNSE vs DSS Comparison
Compare SNSE & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- DSS
- Stock Information
- Founded
- SNSE 2005
- DSS 1984
- Country
- SNSE United States
- DSS United States
- Employees
- SNSE N/A
- DSS N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- SNSE Health Care
- DSS Consumer Discretionary
- Exchange
- SNSE Nasdaq
- DSS Nasdaq
- Market Cap
- SNSE 9.3M
- DSS 8.1M
- IPO Year
- SNSE 2021
- DSS N/A
- Fundamental
- Price
- SNSE $0.34
- DSS $0.85
- Analyst Decision
- SNSE Strong Buy
- DSS
- Analyst Count
- SNSE 4
- DSS 0
- Target Price
- SNSE $4.25
- DSS N/A
- AVG Volume (30 Days)
- SNSE 150.3K
- DSS 13.6K
- Earning Date
- SNSE 05-06-2025
- DSS 05-15-2025
- Dividend Yield
- SNSE N/A
- DSS N/A
- EPS Growth
- SNSE N/A
- DSS N/A
- EPS
- SNSE N/A
- DSS N/A
- Revenue
- SNSE N/A
- DSS $20,180,000.00
- Revenue This Year
- SNSE N/A
- DSS N/A
- Revenue Next Year
- SNSE N/A
- DSS N/A
- P/E Ratio
- SNSE N/A
- DSS N/A
- Revenue Growth
- SNSE N/A
- DSS 12.88
- 52 Week Low
- SNSE $0.25
- DSS $0.72
- 52 Week High
- SNSE $0.87
- DSS $1.90
- Technical
- Relative Strength Index (RSI)
- SNSE 50.22
- DSS 43.41
- Support Level
- SNSE $0.31
- DSS $0.79
- Resistance Level
- SNSE $0.33
- DSS $0.89
- Average True Range (ATR)
- SNSE 0.04
- DSS 0.06
- MACD
- SNSE 0.01
- DSS -0.01
- Stochastic Oscillator
- SNSE 75.25
- DSS 63.77
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.